![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessImetelstat therapy in refractory anemia with ring sideroblasts with or without thrombocytosis
-
Article
Open AccessMolecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations
-
Article
Erratum: Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations
Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations
-
Article
Open AccessPrognostic relevance of lymphocytopenia, monocytopenia and lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience in 889 patients
Current prognostic models for myelodysplastic syndromes (MDS), including the Revised International Prognostic Scoring System (IPSS-R), do not account for host immunity. We retrospectively examined the prognost...
-
Article
Open AccessEuropean LeukemiaNet-defined primary refractory acute myeloid leukemia: the value of allogeneic hematopoietic stem cell transplant and overall response
We sought to appraise the value of overall response and salvage chemotherapy, inclusive of allogeneic hematopoietic stem cell transplant (AHSCT), in primary refractory acute myeloid leukemia (prAML). For estab...
-
Article
Open AccessCore-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with “7+3”